Login to Your Account



2011 J.P. Morgan Healthcare Conference

Orexigen Nears PDUFA as Vivus, Arena Keep Trying

By Tom Wall


Friday, January 14, 2011
SAN FRANCISCO – If there was a trifecta for biotechs developing new weight-loss therapies, presentations by Vivus Inc., Orexigen Therapeutics Inc. and Arena Pharmaceuticals Inc. Wednesday at the J.P. Morgan Healthcare conference would have given you a pretty good idea of who to pick for win, place and show.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription